Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06052514 · ClinicalTrials.gov registry record
CPAP Efficacy in Post-COVID-19 Patients With Sleep Apnea
A clinical trial of COVID-19 and Sleep Apnea, sponsored by Venkatesh Krishnamurthy.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT06052514: Completed study of COVID-19 and Sleep Apnea, sponsored by Venkatesh Krishnamurthy.
NCT06052514 is a study of COVID-19 and Sleep Apnea that has completed, run by Venkatesh Krishnamurthy. The registered enrollment target is 22 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06052514, a study of COVID-19 and Sleep Apnea, has completed, sponsored by Venkatesh Krishnamurthy.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, observational study evaluating the relationship between severity of sleep apnea with severity of cognitive fog and if treatment of sleep apnea with CPAP improves cognitive fog in a cohort of post COVID patients with sleep apnea.
Primary Outcome
Cognitive Fog as measured on Montreal Cognitive Assessment
Conditions Studied
Interventions
- DEVICE Continuous positive airway pressure
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2024-01-04 |
| Est. Completion | 2024-12-31 |
What the finished NCT06052514 record still lists
NCT06052514 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Continuous positive airway pressure is the first listed.
NCT06052514 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06052514 about?
NCT06052514 is a clinical study titled "CPAP Efficacy in Post-COVID-19 Patients With Sleep Apnea". This is a prospective, observational study evaluating the relationship between severity of sleep apnea with severity of cognitive fog and if treatment of sleep apnea with CPAP improves cognitive fog in a cohort of post COVID patients with sleep apnea.
What is the current status of trial NCT06052514?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2024-01-04. Estimated completion is 2024-12-31.
What conditions does trial NCT06052514 study?
This clinical trial studies the following conditions: COVID-19, Sleep Apnea.
What interventions are being tested in trial NCT06052514?
The interventions under investigation include: Continuous positive airway pressure (DEVICE).
Who is sponsoring clinical trial NCT06052514?
This trial is sponsored by Venkatesh Krishnamurthy, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06052514 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06052514's enrollment target sits among peer trials
22 276th of 298 higher than 23 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI